AAAAAA
Results:
1-22
|
Results: 22
Authors:
von der Maase, H
Hayden, AM
Citation: H. Von Der Maase et Am. Hayden, Gemcitabine and cisplatin for advanced, metastatic bladder cancer - In reply, J CL ONCOL, 19(4), 2001, pp. 1229-1231
Authors:
Sengelov, L
Kamby, C
von der Maase, H
Citation: L. Sengelov et al., Metastatic urothelial cancer: Evaluation of prognostic factors and change in prognosis during the last twenty years, EUR UROL, 39(6), 2001, pp. 634-642
Authors:
von Eyben, FE
Madsen, EL
Blaabjerg, O
Petersen, PH
von der Maase, H
Jacobsen, GK
Rorth, M
Citation: Fe. Von Eyben et al., Serum lactate dehydrogenase isoenzyme I and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I, ACTA ONCOL, 40(4), 2001, pp. 536-540
Authors:
von der Maase, H
Citation: H. Von Der Maase, Do we have a new standard of treatment for patients with seminoma stage IIA and stage IIB?, RADIOTH ONC, 59(1), 2001, pp. 1-3
Authors:
von der Maase, H
Citation: H. Von Der Maase, Gemcitabine-containing regimens in bladder cancer: A new standard of care, SEMIN ONCOL, 28(3), 2001, pp. 1-3
Authors:
von der Maase, H
Citation: H. Von Der Maase, Gemcitabine in advanced bladder cancer, SEMIN ONCOL, 28(2), 2001, pp. 11-14
Authors:
von der Maase, H
Citation: H. Von Der Maase, Gemcitabine in locally advanced and/or metastatic bladder cancer, CR R ONC H, 34(3), 2000, pp. 175-184
Authors:
Schmidt, H
Geertsen, PF
Fode, K
Rytter, C
Bastholt, L
von der Maase, H
Citation: H. Schmidt et al., Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study, MELANOMA RE, 10(1), 2000, pp. 66-77
Authors:
von der Maase, H
Citation: H. Von Der Maase, Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer, EUR J CANC, 36, 2000, pp. S13-S16
Authors:
von der Maase, H
Hansen, SW
Roberts, JT
Dogliotti, L
Oliver, T
Moore, MJ
Bodrogi, I
Albers, P
Knuth, A
Lippert, CM
Kerbrat, P
Rovira, PS
Wersall, P
Cleall, SP
Roychowdhury, DF
Tomlin, I
Visseren-Grul, CM
Conte, PF
Citation: H. Von Der Maase et al., Gemcitabine and cisplatin versus methotrexate vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large randomized, multinational, multicenter, phase III study, J CL ONCOL, 18(17), 2000, pp. 3068-3077
Authors:
Sengelov, L
Kamby, C
Geertsen, F
Andersen, LJ
von der Maase, H
Citation: L. Sengelov et al., Predictive factors of response to cisplatin-based chemotherapy and the relation of response to survival in patients with metastatic urothelial cancer, CANC CHEMOT, 46(5), 2000, pp. 357-364
Authors:
Ehrnrooth, E
Sorensen, B
Poulsen, JH
Sorensen, BS
von der Maase, H
Citation: E. Ehrnrooth et al., Changes in thymidylate synthase mRNA in blood leukocytes from patients with colorectal cancer after bolus administration of 5-fluorouracil, ACTA ONCOL, 39(1), 2000, pp. 53-57
Authors:
Sengelov, L
Christensen, M
von der Maase, H
Horn, T
Marcussen, N
Kamby, C
Orntoft, T
Citation: L. Sengelov et al., Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelialcancer and lack of relation to chemotherapy response and outcome, CANC GENET, 123(2), 2000, pp. 109-113
Authors:
Sorensen, BS
Schmidt, H
von der Maase, H
Straten, PT
Nexo, E
Citation: Bs. Sorensen et al., Quantification of melanoma cell-specific MART-I mRNA in peripheral blood by a calibrated competitive reverse transcription-PCR, CLIN CHEM, 46(12), 2000, pp. 1923-1928
Authors:
Ehrnrooth, E
Sorensen, BS
Meldgaard, P
Hornung, N
Poulsen, JH
von der Maase, H
Citation: E. Ehrnrooth et al., A new quantitative RT-PCR assay for thymidylate synthase mRNA in blood leukocytes applied to cancer patients and healthy controls, CLIN CHIM A, 290(2), 2000, pp. 129-144
Authors:
Primdahl, H
von der Maase, H
Christensen, M
Wolf, H
Orntoft, TF
Citation: H. Primdahl et al., Allelic deletions of cell growth regulators during progression of bladder cancer, CANCER RES, 60(23), 2000, pp. 6623-6629
Authors:
von der Maase, H
Andersen, L
Crino, L
Weinknecht, S
Dogliotti, L
Citation: H. Von Der Maase et al., Weekly gemcitabine and cisplatin combination therapy in patients with transitional cell carcinoma of the urothelium: A phase II clinical trial, ANN ONCOL, 10(12), 1999, pp. 1461-1465
Authors:
Aboagye-Mathiesen, G
Ebbesen, P
von der Maase, H
Celis, JE
Citation: G. Aboagye-mathiesen et al., Interferon gamma regulates a unique set of proteins in fresh human bladdertransitional cell carcinomas, ELECTROPHOR, 20(2), 1999, pp. 344-348
Authors:
Sengelov, L
von der Maase, H
Citation: L. Sengelov et H. Von Der Maase, Radiotherapy in bladder cancer, RADIOTH ONC, 52(1), 1999, pp. 1-14
Authors:
Sengelov, L
von der Maase, H
Kamby, C
Jensen, LI
Rasmussen, F
Horn, T
Nielsen, SL
Steven, K
Citation: L. Sengelov et al., Assessment of patients with metastatic transitional cell carcinoma of the urinary tract, J UROL, 162(2), 1999, pp. 343-346
Authors:
Christensen, TB
Engbaek, F
Marqversen, J
Nielsen, SI
Kamby, C
von der Maase, H
Citation: Tb. Christensen et al., I-125-labelled human chorionic gonadotrophin (hCG) as an elimination marker in the evaluation of hCG decline during chemotherapy in patients with testicular cancer, BR J CANC, 80(10), 1999, pp. 1577-1581
Authors:
Christensen, TB
Marqversen, J
Engbaek, F
Berger, P
Bacher, T
von der Maase, H
Citation: Tb. Christensen et al., Validation of I-125-hCG as a marker for elimination of hCG and stability of I-125-hCG after in vivo injection in humans, BR J CANC, 80(10), 1999, pp. 1582-1587
Risultati:
1-22
|